# CytoImmune Therapeutics, Inc. — Form D

CytoImmune Therapeutics, Inc. of Monrovia, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-06. The offering totals $100.3M, of which $36.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-08-06
- Form: D
- Accession: 0001876708-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100.3M
- Amount sold: $36.5M
- Remaining: $63.8M
- Investors: 4
- Date of first sale: 2021-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-409127

## Issuer

- Name: CytoImmune Therapeutics, Inc.
- CIK: 0001876708
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1218 S 5th Ave, Monrovia, CA, 91016
- Phone: 4692222350

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Kinam T Hong | Director | Monrovia, CA |
| Douglas T Williams | Director | Monrovia, CA |
| Aleksey Krylov | Executive Officer | Monrovia, CA |
| Will Rosellini | Executive Officer | New York, NY |
| Richard T Santulli | Executive Officer | Monrovia, CA |

## More

- [CIK 1876708 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1876708&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001876708-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.